Together with three other proteins (APO4, C7, and CLU), ITIH2 is considered a useful biomarker to detect the early stages of diabetic retinopathy, a common microvascular DM complication (Garcia‐Ramirez et al., 2007; Jin et al., 2016). This evidence concerns the gene CLU and diabetic retinopathy.